|
CDK5RAP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.400600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.626200E-01 |
| Normal-vs-Stage2 |
5.160600E-01 |
| Normal-vs-Stage3 |
6.130600E-01 |
| Normal-vs-Stage4 |
6.696800E-01 |
| Stage1-vs-Stage2 |
4.560200E-01 |
| Stage1-vs-Stage3 |
5.235400E-01 |
| Stage1-vs-Stage4 |
6.228000E-01 |
| Stage2-vs-Stage3 |
8.223600E-01 |
| Stage2-vs-Stage4 |
7.941600E-01 |
| Stage3-vs-Stage4 |
9.524200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.568400E-01 |
| Normal-vs-AfricanAmerican |
6.165600E-01 |
| Normal-vs-Asian |
7.731600E-01 |
| Caucasian-vs-AfricanAmerican |
7.655600E-01 |
| Caucasian-vs-Asian |
7.181400E-01 |
| AfricanAmerican-vs-Asian |
6.708800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.774400E-01 |
| Normal-vs-Female |
8.718600E-01 |
| Male-vs-Female |
2.727000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.583400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.887800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.613200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.919000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.412200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.619000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.384800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.018000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.279200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.464400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.215800E-01 |
| Normal-vs-Grade 2 |
7.197600E-01 |
| Normal-vs-Grade 3 |
8.599400E-01 |
| Normal-vs-Grade 4 |
5.738800E-01 |
| Grade 1-vs-Grade 2 |
1.334190E-01 |
| Grade 1-vs-Grade 3 |
7.309900E-02 |
| Grade 1-vs-Grade 4 |
5.289500E-02 |
| Grade 2-vs-Grade 3 |
8.533200E-01 |
| Grade 2-vs-Grade 4 |
7.111000E-01 |
| Grade 3-vs-Grade 4 |
6.544400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.711000E-01 |
| Normal-vs-ccB subtype |
3.166800E-01 |
| ccA subtype-vs-ccB subtype |
2.395900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.298600E-01 |
| Normal-vs-N1 |
8.291000E-01 |
| N0-vs-N1 |
8.097000E-01 |
|
|
